Gara Jalqabaatti › Kansarii Prostate › Wisconsin › Madison
Qorannoo klinikaalii Kansarii Prostate Madison, WI keessatti
Qorannoo 29 Kansarii Prostate f Madison fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Wisconsin Carbone Cancer Center, Madison
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Namoota walitti qabaa jiraSadarkaa 3
- William S Middleton VA Medical Center, Madison
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
PET/CT Characterization of Treatment Resistance
Namoota walitti qabaa jira
- University of Wisconsin, Madison
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Namoota walitti qabaa jiraSadarkaa 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Namoota walitti qabaa jiraSadarkaa 2
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Namoota walitti qabaa jiraSadarkaa 3
- University Hospital and UW Health Clinics ( Site 0065), Madison
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
Namoota walitti qabaa jiraSadarkaa 2
- Carbone Cancer Center University of Wisconsin-Madison, Madison
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Namoota walitti qabaa jiraSadarkaa 3
- University of Wisconsin, Madison
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- UW Health Carbone Cancer Center, Madison
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Wisconsin Carbone Cancer Center, Madison
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Namoota walitti qabaa jiraSadarkaa 2
- University of Wisconsin Carbone Cancer Center-Madison, Madison
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Namoota walitti qabaa jiraSadarkaa 3
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Wisconsin, Carbone Cancer Center, Madison
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Namoota walitti qabaa jiraSadarkaa 1
- University of Wisconsin Carbone Cancer Center, Madison
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Wisconsin-Madison, Madison
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Namoota walitti qabaa jiraSadarkaa 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Namoota walitti qabaa jiraSadarkaa 2
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Namoota walitti qabaa jiraSadarkaa 1
- University of Wisconsin, Madison
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- University of Wisconsin Carbone Cancer Center, Madison
Using FAPI PET/MRI to Evaluate Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Wisconsin, Madison
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Wisconsin Carbone Cancer Center, Madison
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- University of Wisconsin Carbone Cancer Center (UWCCC) - Cancer Connect, Madison
Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
Namoota walitti qabaa jiraSadarkaa 1
- University of Wisconsin - Madison, Madison
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Namoota walitti qabaa jiraSadarkaa 4
- University of Wisconsin, Madison
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Wisconsin-Madison, Madison
Qorannoo Kansarii Prostate magaalota biroo keessatti
- New York City, NYQorannoo 103
- Houston, TXQorannoo 76
- Los Angeles, CAQorannoo 61
- Boston, MAQorannoo 59
- St. Louis, MOQorannoo 46
- Chicago, ILQorannoo 45
- San Francisco, CAQorannoo 45
- Philadelphia, PAQorannoo 44
- Baltimore, MDQorannoo 43
- Nashville, TNQorannoo 42
- Seattle, WAQorannoo 42
- Washington, DCQorannoo 38
Qorannoo biroo Madison keessatti
- Kansarii ColorectalQorannoo 22
- Saree OljooQorannoo 22
- Kansara MetastatikiiQorannoo 21
- Kansara Qara'a Non-Small CellQorannoo 16
- Leukemia Myeloidii HamaaQorannoo 16
- MelanomaQorannoo 15
- Saree (Gosoota Hunda)Qorannoo 14
- Kansarii OvariiQorannoo 13
- Kanisa HarkaaQorannoo 11
- Dhibee QaraQorannoo 10
- Kansarii PancreasQorannoo 10
- Myeloma Baay’eeQorannoo 9
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.